Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
Stopped early
Conditions studied: Human Papilloma Virus
In brief
To determine if the emergency department (ED) setting offers a viable space for improving HPV vaccination coverage among 18 to 45-year-old adults who have not yet received human papilloma virus (HPV) vaccination or who did not complete the vaccine series. This study will develop, pilot and evaluate an ED-based HPV vaccination protocol and program for ED patients aged 18-26 (for whom catch-up HPV vaccination is routinely recommended by the CDC) and separately for patients aged 27-45 (for whom it may be recommended under shared decision making, SDM).
Key facts
- Study ID
- NCT06229353
- Run by
- University of Alabama at Birmingham
- People needed
- 34
- Starts
- 2024-08-08
- Expected to finish
- 2025-07-30
- Last updated by the study team
- 2026-04-20
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- aged 18-45 years old
- in good functional capacity, as determined by the ED-attending clinician
- no known infection with HPV high risk strain types 6, 11, 16 and 18.
You may not qualify if…
- will not receive vaccine if participants lack mental clarity and if running a fever or in some pain.
- Patients aged <18 or > 45 years of age.
- Female patients with abnormal HPV results (including those with the high-risk HPV strain types 6, 11, 16, and 18) as determined by a previous PAP smear test or HPV test.
- Female patients who are known to be pregnant.
- Male patients with known cases of HPV-associated infections will also be excluded from the study
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.